Patents by Inventor Beate Gutterer

Beate Gutterer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for R-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregna,4-dien-11.beta., 16.alpha., 17.alpha.-triol-3,20-dione derivatives
    Patent number: 6787533
    Abstract: R-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregna-1,4-dien-11beta,16alpha,17alpha-triol-3,20-dione derivatives is effected by fractional crystallization.
    Type: Grant
    Filed: February 11, 1999
    Date of Patent: September 7, 2004
    Assignee: Altana Pharma AG
    Inventor: Beate Gutterer
  • Phenanthridine-N-oxides with PDE-IV inhibiting activity
    Patent number: 6538005
    Abstract: The N-oxides of the compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, arm novel active bronchial therapeutics.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: March 25, 2003
    Assignee: ALTANA Pharma AG
    Inventor: Beate Gutterer
  • Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
    Patent number: 6534518
    Abstract: Compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, are novel active bronchial therapeutics.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: March 18, 2003
    Assignee: Altana Pharma AG
    Inventor: Beate Gutterer
  • Phenanthridine-N-oxides with PDE-IV inhibiting activity
    Patent number: 6534519
    Abstract: The N-oxides of the compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, are novel active bronchial therapeutics.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: March 18, 2003
    Assignee: Altana Pharma AG
    Inventor: Beate Gutterer
  • Phenanthridine-n-oxides with pde-iv inhibiting activity
    Publication number: 20020183350
    Abstract: The N-oxides of the compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, arm novel active bronchial therapeutics.
    Type: Application
    Filed: July 12, 2001
    Publication date: December 5, 2002
    Inventor: Beate Gutterer
  • 6-arylphenanthridines with PDE-IV inhibiting activity
    Patent number: 6479505
    Abstract: Compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and Ar have the meanings indicated in the description, are novel active bronchial therapeutics.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: November 12, 2002
    Assignee: Altana Pharma AG
    Inventor: Beate Gutterer
  • Phenylphennanthridines with PDE-IV inhibiting activity
    Patent number: 6476025
    Abstract: Compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51, R6, R13 and R20 have the meaning indicated in the description, are novel active bronchial therapeutics
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: November 5, 2002
    Assignee: Altana Pharma AG
    Inventor: Beate Gutterer
  • Tetrazole derivatives
    Patent number: 6410551
    Abstract: Compounds of formula I, in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, are efficacious bronchial therapeutics.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: June 25, 2002
    Assignee: Byk Gulden Lomberg Chemische Fabrik GmbH
    Inventor: Beate Gutterer
  • Substituted 6-alkylphenanthridines
    Patent number: 6214839
    Abstract: Compounds of formula I pharmaceutically acceptable salts thereof and compositions of either are useful for treating conditions amenable to treatment with a phosphodiesterase inhibitor type 4.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: April 10, 2001
    Assignee: Byk Gulden Lomberg Chemische Fabrik GmbH
    Inventor: Beate Gutterer
  • Phenanthridines
    Patent number: 6191138
    Abstract: Compounds of formula (I), where R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings given in the description, are new active bronchial therapeutic agents.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: February 20, 2001
    Assignee: Byk Gulden Lomberg Chemische Fabrik GmbH
    Inventor: Beate Gutterer
  • Phenanthridines substituted in the 6 position
    Patent number: 6127378
    Abstract: Compounds of the formula I in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, are novel efficacious bronchial therapeutics.
    Type: Grant
    Filed: September 3, 1998
    Date of Patent: October 3, 2000
    Assignee: Byk Gulden Lomberg Chemische Fabrik GmbH
    Inventor: Beate Gutterer
  • Substituted 6-phenylphenanthridines
    Patent number: 6121279
    Abstract: The invention relates to compounds of formula (I): wherein R1, R2, R3, R31, R4, R5, R51 and R6 are as defined in the specification. The compounds are phosphodiesterase inhibitors. Also disclosed are pharmaceutical compositions and methods of use of the compounds.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: September 19, 2000
    Assignee: Byk Gulden Lomberg Chemische Fabrik GmbH
    Inventor: Beate Gutterer
  • Prednisolone derivatives
    Patent number: 5733901
    Abstract: Epimers of the compound having the formula (I) are disclosed, both in their pure form and mixed in any desire mix ratio.
    Type: Grant
    Filed: September 29, 1995
    Date of Patent: March 31, 1998
    Assignee: BYK Gulden Lomberg Chemische Fabrik GmbH
    Inventor: Beate Gutterer
  • Silyl Compounds and their use
    Patent number: 5728826
    Abstract: The invention describes a process for the epimer enrichment of compounds of formula (I) by silation, fractionated crystallization and acid hydrolysis.
    Type: Grant
    Filed: November 25, 1996
    Date of Patent: March 17, 1998
    Assignee: Byk Gulden Lomberg Chemische Fabrik GmbH
    Inventor: Beate Gutterer